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Cirrhosis is a common disease inWestern countries. Liver failure, hyperammonemia, and portal hypertension are the main factors
that contribute to human cirrhosis that frequently leads to a neuropsychiatric disorder known as hepatic encephalopathy (HE).
In this study, we examined the differential contribution of these leading factors to the oxidative metabolism of diverse brain
limbic system regions frequently involved in memory process by histochemical labelling of cytochrome oxidase (COx). We have
analyzed cortical structures such as the infralimbic and prelimbic cotices, subcortical structures such as hippocampus and ventral
striatum, at thalamic level like the anterodorsal, anteroventral, and mediodorsal thalamus, and, finally, the hypothalamus, where
the mammillary nuclei (medial and lateral) were measured. The severest alteration is found in the model that mimics intoxication
by ammonia, followed by the thioacetamide-treated group and the portal hypertension group. No changes were found at the
mammillary bodies for any of the experimental groups.
1. Introduction
Portal hypertension is one of the main complications of
human cirrhosis that frequently leads to a neuropsychiatric
disorder known as hepatic encephalopathy (HE).The genesis
of portal hypertension implies an increase in vascular resis-
tance that can occur at any level within the portal venous
system [1]. Elevated blood flow and brain ammonia levels
have been strongly implicated in the pathogenesis of HE [2].
Ammonia is a common etiological factor in HE as well as
in various hyperammonemic conditions, including inborn
errors of the urea cycle, Reye’s syndrome, valproate toxicity,
idiopathic hyperammonemia, and other conditions [3–6].
Elevated ammonia and its chief metabolite, glutamine, are
believed to be important factors responsible for altered cere-
bral functions, including multiple neurotransmitter system
failures, altered bioenergetics, and oxidative stress [7].
Likewise, patients with liver disease have HE, which
incorporates a spectrum of manifestations including
psychomotor dysfunction, increased reaction time, sensory
abnormalities, and poor concentration [8]. Depending on
the definition used, HE prevalence varies between 30–84%
in patients with cirrhosis [9], a common disease in Western
countries [10]. In humans, few studies have been carried
out on memory alterations in patients with cirrhosis who
develop HE, and, although some authors argue that memory
disturbances are not a major symptom of HE [11], others
state that patients with HE present clear mnesic alterations.
Hence, Bahceci et al. [12] found a poorer performance in
several memory tests in patients with cirrhosis, whereas
Ortiz et al. [13] showed a learning deficit and impairment in
long-term memory.
Taken together, liver disease, portal hypertension, and
hyperammonemia appear to be themain contributing factors
that lead to the occurrence of HE.
According to the proposal of Butterworth et al. [14], HE
is reclassified into different types, depending on its origin or
cause. Type B concerns HE related to portosystemic shunt,
2 International Journal of Hypertension
which does not necessarily involve any hepatocytic alteration
and includes portocaval shunt, partial ligature of the portal
vein, and triple portal vein ligation [15]. Type C is associated
with chronic liver failure (cirrhosis). As HE can be derived
from different causes, diverse experimental models have
been developed to reproduce the characteristics of HE as
closely as possible and to study brain dysfunction in this
syndrome [14]. In this study, we try to isolate themain factors
leading to HE through the use of three experimental models:
portal hypertension, hyperammonemia, and thioacetamide.
Portal hypertension by triple portal vein ligation [16] involves
collateral circulation but with a discrete hepatocellular insuf-
ficiency. The model of hyperammonemia [17] allowed us to
study the effect of ammonia as a toxic brain substance but
it lacks also liver failure [18]. Therefore, to explore cirrhosis,
a model of chronic thioacetamide administration was used
[19].
Difficulties learning diverse types of tasks have been
shown in these experimental models, such as classical con-
ditioning [20], conditional discrimination [21, 22], reference
[23], and working memory [24]. However, less is known
about the specific role of liver failure, portal hypertension,
and hyperammonemia in the development of bioenergetic
brain disturbances.
The aim of this study is to elucidate the differential con-
tribution of these leading factors to the oxidative metabolism
of diverse brain limbic system regions frequently involved in
memory process by histochemical labelling of cytochrome
oxidase (COx). COx is a mitochondrial enzyme involved in
the phosphorylation process that generates ATP. This energy
is used to maintain the resting membrane potential and the
synthesis of molecules and neurotransmitters, among other
functions [25]. Because metabolic activity is tightly coupled
with neuronal activity, this technique can be used as an index
of regional functional activity in the brain, reflecting changes
in tissue metabolic capacity induced by sustained energy
requirements of the nervous system associated with learning
[23, 26].
2. Material and Methods
2.1. Subject. A total of 28 male adult Wistar rats were used
(230–260 g at the start of the experiments) from the animalar-
ium of Oviedo University. All the animals had ad libitum
access to food and tap water and were maintained under
standard laboratory conditions (20–22∘C, 65–70% relative
humidity, and a 12 h light/dark cycle). The procedures and
manipulation of the animals used in this study were carried
out according to the European Parliament and the Council of
the European Union 2010/63/UE and were approved by the
Oviedo University committee for animal studies.
2.2. Procurement of Experimental Models. The animals were
randomly distributed into 3 groups: portal hypertension (PH
group, 𝑛 = 12), hyperammonemia (HA group, 𝑛 = 8), and
animals with cirrhosis by administration of thioacetamide
(TAA group, 𝑛 = 8). The surgical procedures and protocols
used for the different experimental models are described
below.
2.2.1. Portal Hypertension. The portal hypertension model
was carried out under induction of anaesthesia by i.m.
injection of ketamine (100mg/kg) and xylacine (12mg/kg).
A midline abdominal incision was performed and a part of
the intestinal loops was gently shifted to the left and covered
with saline-moistened gauze. The portal vein was isolated
along its length. Portal hypertension was produced by triple
partial ligation [16].Three stenosing ligatureswere performed
in the superior, medial, and inferior portions of the portal
vein, respectively, andmaintained in position by the previous
fixation of the ligatures to a sylastic guide. The stenoses were
also calibrated by a simultaneous ligature (3–0 silk) around
the portal vein and a 20Gneedle.The abdominal incisionwas
closed in two layers with an absorbable suture (polyglycolic
acid) and 3–0 silk. With respect to postsurgical care, the
rats were maintained close to a source of heat until they
recovered consciousness (10–15min) to avoid postoperative
hypothermia. Brains were assessed 45 days later.
2.2.2. Thioacetamide. The method used to produce cirrhosis
was weekly administration of thioacetamide (Sigma, Ger-
many) in drinking water as described by Li et al. [19]. The
thioacetamide (TAA) was administered for 12 weeks and
its concentration was modified weekly depending on the
animals’ weight gain or weight loss. The initial concentration
of TAAwas 0.03%. After twelve weeks of treatment, they were
placed in groups of 5 rats per cage and theywere assessed after
two weeks. During this period, the animals received TAA at
0.04%.
2.2.3. Hyperammonemia. The method used to produce
hyperammonemia was performed according to Azor´ın et
al. [17]. Briefly, the animals were fed with a standard diet
supplemented with ammonium acetate ad libitum for up to
27 days.
2.3. CytochromeOxidase Histochemistry. 90minutes after the
performance of a spatial reference memory task, animals
were decapitated, and the brains were removed intact, frozen
rapidly in isopentane (Sigma-Aldrich), and stored at −40∘C.
Coronal sections (30 𝜇m) of the brain were cut at −20∘C in
a cryostat (Leica CM1900, Germany) and were mounted on
slides.
We used a quantitative COx histochemistry described by
Gonzalez-Lima andCada [25]. To quantify enzymatic activity
and to control staining variability across different baths of
staining, sets of tissue homogenate standards obtained from
Wistar rat brainswere includedwith each bath of slides.These
standards were cut at different thicknesses (10, 30, 40, and
60𝜇m).
Sections and standards were incubated for 5min in
0.1M phosphate buffer with 10% w/v sucrose and 0.5%
v/v glutaraldehyde, pH 7.6. After this, four baths of 0.1M
phosphate buffer with 10% w/v sucrose were given for 5min
each. Then 0.05M Tris buffer, pH 7.6, with 275mg/L cobalt
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chloride, 10% w/v sucrose, and 0.5% v/v dimethylsulfox-
ide were applied for 10min, to enhance staining contrast.
Subsequently, sections and standards were incubated in a
solution of 0.06 g cytochrome c (Sigma, St. Louis, MO,
USA), 0.016 g catalase, 40 g sucrose, 2mL dimethylsulfoxide,
and 0.4 g diaminobenzidine tetrahydrochloride in 800mL
of 0.1M phosphate buffer, at 37∘C for 1 h. The reaction was
stopped by fixing the tissue in buffered formalin for 30min at
room temperaturewith 10%w/v sucrose and 4%v/v formalin.
Finally, the slides were dehydrated in series of ethanol baths
(from 30% to 100% v/v ethanol), cleared with xylene, and
coverslipped with Entellan (Merck, Germany).
2.3.1. Quantification. Quantification of COx histochemical
staining intensity was done by densitometric analysis using
a computer-controlled image analysis workstation (MCID,
InterFocus Imaging Ltd., Linton, England)made up of a high-
precision illuminator, a digital camera, and a computer with
specific software for image analysis.Themean optical density
(OD) of each structure was measured on the right side of
the bilateral structures using three consecutive sections of
each animal. In each section, four nonoverlapping readings
were taken using a square-shaped sampling window that was
adjusted for each region size. A total of twelve measurements
were taken per region. These twelve measurements were
averaged to obtain one mean per region for each subject. OD
values were then converted to COx activity units, determined
by the enzymatic activity of the standards which were
measured spectrophotometrically [25]. Measurements were
performed by an investigator blind to the groups.
The regions of interest were anatomically defined accord-
ing to Paxinos and Watson (2005) [27]. The regions of
interest and the distance in mm of the regions counted from
bregmawere: +3.20mm for prefrontal cortex (the infralimbic
cortex and prelimbic cortex (IL and PL, resp.), +2.28mm for
ventral striatum (accumbens core and shell, AcC and AcS),
−1.40 for the anterodorsal thalamus (ADT), the anteroventral
thalamus (AVT), and the mediodorsal (MDT), −1.20mm
for the CA1, CA3, and the dentate gyrus (DG) subfields of
the dorsal hippocampus, and +4.52mm for the medial part
of the medial mammillary nucleus (mMM), the lateral part
of the medial mammillary nucleus (lMM), and the lateral
mammillary nucleus (LM). See Figure 1.
2.4. Data Analysis. All data were analyzed in the Sigma-Stat
3.2 program (Systat, Richmond, USA) and were expressed as
mean ± SEM. A one-way analysis of variance was performed
(factor: group). When a significant effect was found post
hoc paired Tukey’s test was carried out. The results were
considered as statistically significant if 𝑃 < 0.05.
3. Results
Thepost hoc paired Tukey’s tests showed differences between
groups in their prefrontal cortex COx activity. The HA group
showed higher activity than the PH and TAA groups in the
PL (F2, 24 = 47.674) (𝑃 < 0.001), and the TAA group also
showed higher activity than the PH group (𝑃 < 0.001). In
Scale bar = 1 mm
Figure 1: Cytochrome oxidase (COx) histochemistry in the sampled
regions in which the squares used to take the measures were
presented. Prelimbic (PL) and infralimbic (IL) cortex, accumbens
core and shell (AcC and AcS), thalamic nuclei (ADT, AVT, and
MDT), dorsal hippocampus (CA1, CA3, and DG) and Mammillary
nuclei (mMM, lMM, and LM). Scale bar: 1mm.
the IL, the same difference between the HA group and the
other groups was found (F2, 24 = 53.649, 𝑃 < 0.001). In
the ventral striatum, the same pattern of metabolic activity
was found in the AcC and AcS, with the HA group showing
higher activity, followed by the TAA group, which differed
from the PH group (F2, 25 = 69.662, 𝑃 < 0.001; F2, 25 =
76.819, 𝑃 < 0.01, resp.). These differences were also found
in the ADT (F2, 25 = 63.441, 𝑃 < 0.001). However, in the
AVT (F2, 25 = 13.610, 𝑃 < 0.05) and MDT (F2, 25 = 27.970,
𝑃 < 0.001), differences were only found when comparing
the HA group with the other experimental groups, with the
former group being themost highly activated. Examining the
dorsal hippocampus, in theDG, theHA group showed higher
activity than the PH and TAA groups (F2, 25 = 47.402, 𝑃 <
0.01), and the TAA group showed greater activity than the
PH group (𝑃 < 0.001). Similarly, in CA3, the HA group was
the most highly activated in relation to the other two groups
(F2, 25 = 63.059, 𝑃 < 0.001), and the TAA group showed
lower activity than the PH group (𝑃 < 0.001). In CA1, the
highest metabolic activity was found in the HA group, which
presented differenceswith the PHand theTAAgroups (F2, 25
= 16.954, 𝑃 < 0.001). Finally, no differences were found in
any of themammillary nuclei explored:mMM(F2, 24 = 0.109,
𝑃 = 0.898), lMM (F2, 24 = 1.368, 𝑃 = 0.274), and LM (F2, 23
= 0.178, 𝑃 = 0.838). See Table 1.
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Table 1: Metabolic activity of the selected brain regions in the studied groups.
PH HA TAA
Prefrontal cortex
PL 18.364 ± 0.460a,b 26.781 ± 1.032 22.591 ± 0.379a
IL 18.470 ± 0.504a 26.988 ± 0.916 19.432 ± 0.401a
Ventral Striatum
AcC 21.362 ± 0.395a,b 31.812 ± 1.032 25.552 ± 0.498a
AcS 22.210 ± 0.748a,b 36.940 ± 1.227 32.409 ± 0.715a
Thalamic nuclei
ADT 30.525 ± 0.736a,b 50.930 ± 2.024 40.025 ± 1.302a
AVT 24.717 ± 0.525a 31.753 ± 1.412 27.631 ± 1.120a
MDT 19.307 ± 0.879a 27.361 ± 0.809 18.242 ± 0.921a
Hippocampus
DG 23.413 ± 0.500a,b 39.550 ± 1.75 32.663 ± 1.739a
CA3 16.318 ± 0.488a,b 22.633 ± 0.763 12.592 ± 0.568a
CA1 18.128 ± 0.707a 24.820 ± 0.915 18.250 ± 0.915a
Mammillary nuclei
mMM 22.949 ± 1.151 23.490 ± 1.336 23.769 ± 1.479
lMM 17.643 ± 0.950 16.792 ± 0.633 15.777 ± 0.597
LM 25.923 ± 1.113 26.624 ± 1.246 26.665 ± 0.489
Values are mean ± SEM.
PH: portal hypertension, HA: hyperammonemia, TAA: thioacetamide.
a
𝑃 < 0.05 statistically significant value in relation to HA.
b
𝑃 < 0.05 statistically significant value in relation to TAA.
4. Discussion
The rationale for the present study arose from evidence
that cerebral metabolic rate for glucose has consistently
been reported to be decreased in patients with chronic HE,
suggesting that hypometabolism contributes to the neuropsy-
chiatric symptoms commonly observed in HE. In fact, it
has been shown that cerebral oxygen metabolism and blood
flow were decreased in cirrhotic patients with HE [28], and
cognitive deficits are closely related to aberrant baseline brain
activity measured by fMRI in these patients [29]. However,
the existence of a differential contribution of factors, such as
portal hypertension, hyperammonemia, and liver disease, to
brain metabolic activity has not yet been explored. In this
study, we demonstrated that each of these factors affects brain
energy requirements to a different extent.
Several studies have assessed these experimental models
in a spatial reference memory task. Whereas the portal
hypertension model showed only mild impairment in this
learning process [23], hyperammonemia and liver failure
models were severely affected (Arias et al., unpublished
results [30]).
Traditionally, the hippocampus has been widely shown
to be involved in reference memory [31]. Specifically, it
is important in establishing allocentric relations [32] and
also seems to be responsible for correct goal recognition
[33]. Together with this brain structure, prefrontal cortex,
ventral striatum, anterior thalamus, and mammillary bodies
cooperate in diverse memory processes and learning tasks
[34, 35]. The role of the prefrontal cortex in the organization
of spatially directed behaviours has been shown both in
primates and humans. In rats, the main evidence comes
from lesion studies in performance of various spatial tasks
such as spatial alternation, spatial reversal, elimination in the
radial maze, and navigation in the Morris water maze [36].
The connections between this prefrontal cortex and ventral
striatum play a role in the transformation of route planning
into motor response in memory tasks [37]. Likewise, the pre-
frontal cortex receives projections from the anterior thalamic
nucleus [38], damage to which impairs allocentric memory
tasks that are also disrupted by hippocampal dysfunctions
[39]. The mammillary nuclei, which can be subdivided
into the medial and lateral parts, are connected with the
hippocampus and send projections to the anterior thalamus
[40] and are involved in spatial memory processes [41, 42].
When we wondered about the possible time-dependent
involvement of these structures in the spatial reference
memory, we found that most of them were differentially
implicated at the beginning and the conclusion of the task
in nonpathological conditions [43]. That is, some structures,
such as the anterior thalamic nuclei and the mammillary
bodies, seem to be more involved in early task acquisition,
but it is necessary for these structures to reduce their energy
requirements in order to successfully complete the task. But
other structures, such as DG, CA3, and the prefrontal cortex,
showed an opposite pattern [43].
In view of this tendency, we were willing to explore the
metabolic activity of the main contributing factors of HE.
Accordingly to our expectations, the portal hypertension
group reduced its metabolic activity in almost all studied
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regions compared to the other groups. A possible explanation
for this behaviour, so similar to that of nonpathological
subjects, is that, in the PH model, portosystemic collaterals
develop as a consequence of high pressure in the portal vein
and ameliorate the increased resistance [1, 44]. However, a
different situation takes place in the HA group, in which the
energetic demands increase above conventional levels. This
increase in oxygen utilization could be due to an inflam-
mation in these areas of the central nervous system [45].
Inflammation will increase the use of oxygen, represented by
excess production of reactive oxygen and nitrogen species,
which cause oxidative and nitrosative stress [46–48].
Several studies have shown that once ammonia crosses
the blood brain barrier, it is immediately used to amidate
glutamate to glutamine in the astrocytes in order to prevent
its toxicity from damaging the neurons. But this depletion
of the substrate of the tricarboxylic acid cycle together with
the inhibition by the ammonia to rate limit enzymes such as
pyruvate dehydrogenase and 𝛼-ketoglutarate will slow down
overall oxidative metabolism, leading to depletion of energy-
rich phosphate compounds [49]. Moreover, glutamatergic
neurotransmission suffers disturbances owing to the fact that
ammonia impairs the induction of NMDA receptors, which
alters the neural glutamate-nitric oxide cyclic GMP pathway,
in turn, involved in learning and memory [20, 21].
At the same time, glutamine, which is an osmotically
powerful substance, increases due to ammonia in the brain
and can provoke a rapid brain edema, triggering intracranial
hypertension. During liver failure, high arterial ammonia
levels lead to accumulation in the brain [50] and exert
numerous deleterious effects, contributing to the clinical
presentation of HE. Subsequent studies carried out in various
animal models of acute and chronic HE, such as our TAA
model, have reported altered glucose utilization similar to the
HA models [51]. But, whereas patients with liver cirrhosis
have a compensatory mechanism that prevents the occur-
rence of brain edema and intracranial hypertension [18], the
hyperammonemic brain cannot establish these mechanisms.
Another possible mechanism for impaired energy
metabolism in HA is the mitochondrial permeability
transition of the inner membrane, which has a critical
linkage with disturbed cerebral energy metabolism and
oxidative/nitrosative stress [51]. Similar to free radicals,
nitric oxide increases in the brain of the TAA-administration
rat model [52]. A possible explanation for the alteration
of COx activity would be the increased level of oxidative
stress [45]. Liver disease is associated with the production
of free radicals that override the balance between oxidative
stress and antioxidative mechanisms, leading to oxidative
stress. Oxidative stress could play a role in the pathogenesis
of HE, due to the fact that the brain of patients with HE is
particularly susceptible to oxidative damage [47]. Peroxidase
damage and increased oxidative stress have been reported
in neural membranes of rats with thioacetamide-induced
HE [53] and in diverse central nervous system regions of
the same animal model [54]. Brain oxidative and nitrosative
(superoxide anion with nitric oxide produces peroxynitrite)
stress in cirrhotic rats could cause neural mitochondrial
damage and defective oxidative phosphorylation, which is
reflected in impaired COx activity. Therefore, oxidative and
nitrosative stress caused activation of the nuclear factor KB,
which is the major inducer of proinflammatory cytokines
and chemokines.
The differences found in bioenergetic requirements could
indicate a differential affectation of the neural networks
underlying different behaviours, so a broad field of future
research opens up.
In conclusion, the results obtained show that there is a dif-
ferential contribution of portal hypertension, hyperammone-
mia, and liver disease to the brain metabolic dysfunction
associated with HE. The most interesting finding is that the
alterations in metabolic brain activity do not develop equally
in the three models. The severest alteration is found in the
model that mimics intoxication by ammonia, where themain
cerebral structures have to make a big effort in comparison
with the other two experimental models.
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